MCMCB Pro
838

MS-DRG 838CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT

DRGMedicalMDC 17

FY2026 payment factors

Relative weight
2.0874
Geometric mean LOS
5.10
Arithmetic mean LOS
6.70
Post-acute transfer
No

Other DRGs in MDC 17

The with-MCC, with-CC and without-CC/MCC splits usually sit next to each other here. Those are what a documentation query is actually deciding between, and the weight gap between them is why the query is worth raising.

  • 820LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC5.8648
  • 821LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC2.2386
  • 822LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC1.2040
  • 823LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC4.5848
  • 824LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC2.2656
  • 825LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC1.3494
  • 826MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC4.6778
  • 827MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC2.3112
  • 828MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC1.7038
  • 829MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC3.1600
  • 830MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC1.5050
  • 834ACUTE LEUKEMIA WITH MCC5.4899
  • 835ACUTE LEUKEMIA WITH CC2.0858
  • 836ACUTE LEUKEMIA WITHOUT CC/MCC1.2195
  • 837CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC4.8043
  • 839CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC1.4439
  • 840LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC3.2349
  • 841LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC1.6314
  • 842LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC1.0104
  • 843OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC1.9948
  • 844OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC1.2174
  • 845OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC0.8516
  • 846CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC2.5925
  • 847CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC1.3082
  • 848CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC0.8494
  • 849RADIOTHERAPY2.7095
  • 850ACUTE LEUKEMIA WITH OTHER PROCEDURES8.6595
MS-DRG (IPPS Table 5)FY2026